Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
27.46 USD | +1.01% | +8.85% | -4.50% |
04:27pm | Morgan Stanley Adjusts Price Target on Pfizer to $29 From $28 | MT |
12:51pm | Leerink Adjusts Price Target on Pfizer to $29 From $27 | MT |
Financials (USD)
Sales 2024 * | 60.15B | Sales 2025 * | 62.48B | Capitalization | 154B |
---|---|---|---|---|---|
Net income 2024 * | 7.91B | Net income 2025 * | 9.98B | EV / Sales 2024 * | 3.45 x |
Net Debt 2024 * | 53.77B | Net Debt 2025 * | 42.59B | EV / Sales 2025 * | 3.14 x |
P/E ratio 2024 * |
18
x | P/E ratio 2025 * |
13.8
x | Employees | 88,000 |
Yield 2024 * |
6.23% | Yield 2025 * |
6.34% | Free-Float | 59.09% |
Latest transcript on Pfizer, Inc.
1 day | +2.34% | ||
1 week | +9.68% | ||
Current month | +8.14% | ||
1 month | +0.56% | ||
3 months | +2.88% | ||
6 months | -9.16% | ||
Current year | -3.77% |
Managers | Title | Age | Since |
---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 92-12-31 |
David Denton
DFI | Director of Finance/CFO | 59 | 22-05-01 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 19-06-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 66 | 20-03-31 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 17-02-22 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 13-09-26 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
14.74% | 215 M€ | +12.38% | - | |
9.37% | 18 M€ | +3.01% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-02 | 27.48 | +1.12% | 20 182 889 |
24-05-01 | 27.18 | +6.09% | 97,521,564 |
24-04-30 | 25.62 | -0.08% | 38,017,739 |
24-04-29 | 25.64 | +0.94% | 41,674,405 |
24-04-26 | 25.4 | +0.55% | 46,526,457 |
Delayed Quote Nyse, May 02, 2024 at 10:24 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-3.77% | 154B | |
+31.87% | 699B | |
+26.39% | 571B | |
-3.81% | 364B | |
+18.47% | 326B | |
+2.41% | 286B | |
+14.66% | 236B | |
+4.58% | 198B | |
-11.86% | 194B | |
-3.70% | 149B |
- Stock Market
- Equities
- PFE Stock